Clinical Trial Update: The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment [NA]

View source ↗

Summary

This clinical trial update outlines a neoadjuvant study evaluating the efficacy and safety of combining CDK4/6 inhibitors with endocrine therapy in stage II-III…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CDK4/6 inhibitors

Snippet

Sponsor: Hongmei Zheng, PhD | Conditions: Breast Cancer Stage III, Breast Cancer Stage II | NA | Status: NOT_YET_RECRUITING